Kissei Pharmaceutical Co., Ltd. (TYO: 4547)
Japan
· Delayed Price · Currency is JPY 3,445.00
-65.00 (-1.85%)
Dec 20, 2024, 3:45 PM JST
Kissei Pharmaceutical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 81,067 | 75,579 | 67,493 | 65,381 | 69,044 | 63,234 | Upgrade
|
| Revenue Growth (YoY) | 13.21% | 11.98% | 3.23% | -5.31% | 9.19% | -12.54% | Upgrade
|
| Cost of Revenue | 40,629 | 38,238 | 35,118 | 34,143 | 36,321 | 28,329 | Upgrade
|
| Gross Profit | 40,438 | 37,341 | 32,375 | 31,238 | 32,723 | 34,905 | Upgrade
|
| Selling, General & Admin | 24,122 | 20,790 | 20,289 | 19,923 | 19,607 | 21,133 | Upgrade
|
| Research & Development | 9,474 | 9,474 | 10,391 | 10,363 | 9,626 | 10,767 | Upgrade
|
| Other Operating Expenses | 143 | 143 | 149 | 137 | 149 | 163 | Upgrade
|
| Operating Expenses | 36,656 | 33,324 | 33,518 | 32,640 | 31,217 | 33,048 | Upgrade
|
| Operating Income | 3,782 | 4,017 | -1,143 | -1,402 | 1,506 | 1,857 | Upgrade
|
| Interest Expense | -18 | -18 | -20 | -23 | -23 | -23 | Upgrade
|
| Interest & Investment Income | 1,326 | 1,318 | 1,402 | 1,586 | 1,272 | 1,227 | Upgrade
|
| Currency Exchange Gain (Loss) | -231 | -103 | 186 | -60 | -130 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 24 | 35 | 57 | 280 | 131 | 169 | Upgrade
|
| EBT Excluding Unusual Items | 4,883 | 5,249 | 482 | 381 | 2,756 | 3,230 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9,406 | 9,119 | 13,133 | 16,161 | 4,727 | 1,433 | Upgrade
|
| Gain (Loss) on Sale of Assets | -56 | 80 | 63 | -35 | -10 | -35 | Upgrade
|
| Asset Writedown | -128 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | -2 | -1 | 1 | -1 | 3 | 1 | Upgrade
|
| Pretax Income | 14,103 | 14,447 | 13,679 | 16,506 | 7,476 | 4,629 | Upgrade
|
| Income Tax Expense | 3,320 | 3,159 | 3,046 | 3,475 | 2,098 | 1,741 | Upgrade
|
| Earnings From Continuing Operations | 10,783 | 11,288 | 10,633 | 13,031 | 5,378 | 2,888 | Upgrade
|
| Minority Interest in Earnings | -52 | -128 | -105 | -110 | -93 | -71 | Upgrade
|
| Net Income | 10,731 | 11,160 | 10,528 | 12,921 | 5,285 | 2,817 | Upgrade
|
| Net Income to Common | 10,731 | 11,160 | 10,528 | 12,921 | 5,285 | 2,817 | Upgrade
|
| Net Income Growth | -16.68% | 6.00% | -18.52% | 144.48% | 87.61% | -48.60% | Upgrade
|
| Shares Outstanding (Basic) | 44 | 45 | 46 | 46 | 47 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 44 | 45 | 46 | 46 | 47 | 47 | Upgrade
|
| Shares Change (YoY) | -3.52% | -1.86% | - | -1.18% | -0.11% | - | Upgrade
|
| EPS (Basic) | 241.69 | 246.58 | 228.30 | 280.19 | 113.25 | 60.30 | Upgrade
|
| EPS (Diluted) | 241.69 | 246.58 | 228.30 | 280.19 | 113.25 | 60.30 | Upgrade
|
| EPS Growth | -13.65% | 8.01% | -18.52% | 147.41% | 87.81% | -48.60% | Upgrade
|
| Free Cash Flow | 790 | -2,878 | -8,782 | 44 | -3,473 | 13,055 | Upgrade
|
| Free Cash Flow Per Share | 17.79 | -63.59 | -190.44 | 0.95 | -74.42 | 279.45 | Upgrade
|
| Dividend Per Share | 41.000 | 82.000 | 80.000 | 56.000 | 54.000 | 52.000 | Upgrade
|
| Dividend Growth | -49.38% | 2.50% | 42.86% | 3.70% | 3.85% | 4.00% | Upgrade
|
| Gross Margin | 49.88% | 49.41% | 47.97% | 47.78% | 47.39% | 55.20% | Upgrade
|
| Operating Margin | 4.67% | 5.31% | -1.69% | -2.14% | 2.18% | 2.94% | Upgrade
|
| Profit Margin | 13.24% | 14.77% | 15.60% | 19.76% | 7.65% | 4.45% | Upgrade
|
| Free Cash Flow Margin | 0.97% | -3.81% | -13.01% | 0.07% | -5.03% | 20.65% | Upgrade
|
| EBITDA | 8,269 | 8,271 | 2,966 | 2,328 | 4,654 | 4,419 | Upgrade
|
| EBITDA Margin | 10.20% | 10.94% | 4.39% | 3.56% | 6.74% | 6.99% | Upgrade
|
| D&A For EBITDA | 4,487 | 4,254 | 4,109 | 3,730 | 3,148 | 2,562 | Upgrade
|
| EBIT | 3,782 | 4,017 | -1,143 | -1,402 | 1,506 | 1,857 | Upgrade
|
| EBIT Margin | 4.67% | 5.31% | -1.69% | -2.14% | 2.18% | 2.94% | Upgrade
|
| Effective Tax Rate | 23.54% | 21.87% | 22.27% | 21.05% | 28.06% | 37.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.